Transmucosal Delivery – Using the Mucofilm® Technology to Bypass the First Pass Effect

12:15 - 12:50

The oral mucosa seems to be the ideal location for delivering large APIs systemically and still avoiding the first pass effect. Certain challenges arise when developing such a dosage form. The product has to adhere on a wet and high mobile surface, needs to resist enzymatic degradation and increased saliva flow and has to simple disappear after a few minutes or a few hours. Challenges that can be overcome to develop the next generation of large molecule application systems.

Dr. Ahmad Ghoniem, Pharmacist - Business Development Manager , tesa Labtec North America